CLINICAL_TRIALS
trial_result
· 2014-12-12
Clinical Trial Update: Transepithelial Corneal Collagen Cross-linking (CXL) in Treatment of Keratoconus [Phase 2]
Summary
Phase 2 study investigating transepithelial corneal collagen cross-linking for keratoconus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital of North Norway | Conditions: Keratoconus | Phase 2 | Status: COMPLETED